Mathematical Analysis of the Role of HIV/HBV Latency in Hepatocytes

The biggest challenge of treating HIV is rampant liver-related morbidity and mortality. This is, to some extent, attributed to hepatocytes acting as viral reservoirs to both HIV and HBV. Viral reservoirs harbour latent provirus, rendering it inaccessible by combinational antiretroviral therapy (cART...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hasifa Nampala, Matylda Jablonska-Sabuka, Martin Singull
Formato: article
Lenguaje:EN
Publicado: Hindawi Limited 2021
Materias:
Acceso en línea:https://doaj.org/article/a0b00266979c4b64b0e039ba9997e2de
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a0b00266979c4b64b0e039ba9997e2de
record_format dspace
spelling oai:doaj.org-article:a0b00266979c4b64b0e039ba9997e2de2021-11-29T00:56:51ZMathematical Analysis of the Role of HIV/HBV Latency in Hepatocytes1687-004210.1155/2021/5525857https://doaj.org/article/a0b00266979c4b64b0e039ba9997e2de2021-01-01T00:00:00Zhttp://dx.doi.org/10.1155/2021/5525857https://doaj.org/toc/1687-0042The biggest challenge of treating HIV is rampant liver-related morbidity and mortality. This is, to some extent, attributed to hepatocytes acting as viral reservoirs to both HIV and HBV. Viral reservoirs harbour latent provirus, rendering it inaccessible by combinational antiretroviral therapy (cART) that is specific to actively proliferating virus. Latency reversal agents (LRA) such as Shock and kill or lock and block, aiming at activating the latently infected cells, have been developed. However, they are CD4+ cell-specific only. There is evidence that the low replication level of HIV in hepatocytes is mainly due to the latency of the provirus in these cells. LRA are developed to reduce the number of latently infected cells; however, the impact of the period viral latency in hepatocytes especially, during HIV/HBV coinfection, needs to be investigated. Viral coinfection coupled with lifelong treatment of HIV/HBV necessitates investigation for the optimal control strategy. We propose a coinfection mathematical model with delay and use optimal control theory to analyse the effect of viral latency in hepatocytes on the dynamics of HIV/HBV coinfection. Analytical results indicate that HBV cannot take a competitive exclusion against HIV; thus, the coinfection endemic equilibrium implies chronic HBV in HIV-infected patients. Numerical and analytical results indicate that both HIV and HBV viral loads are higher with longer viral latency period in hepatocytes, which indicates the need to upgrade LRA to other non-CD4+ cell viral reservoirs. Higher viral load caused by viral latency coupled with the effects of cART partly explains why liver-related complications are the leading cause of mortality in HIV-infected persons.Hasifa NampalaMatylda Jablonska-SabukaMartin SingullHindawi LimitedarticleMathematicsQA1-939ENJournal of Applied Mathematics, Vol 2021 (2021)
institution DOAJ
collection DOAJ
language EN
topic Mathematics
QA1-939
spellingShingle Mathematics
QA1-939
Hasifa Nampala
Matylda Jablonska-Sabuka
Martin Singull
Mathematical Analysis of the Role of HIV/HBV Latency in Hepatocytes
description The biggest challenge of treating HIV is rampant liver-related morbidity and mortality. This is, to some extent, attributed to hepatocytes acting as viral reservoirs to both HIV and HBV. Viral reservoirs harbour latent provirus, rendering it inaccessible by combinational antiretroviral therapy (cART) that is specific to actively proliferating virus. Latency reversal agents (LRA) such as Shock and kill or lock and block, aiming at activating the latently infected cells, have been developed. However, they are CD4+ cell-specific only. There is evidence that the low replication level of HIV in hepatocytes is mainly due to the latency of the provirus in these cells. LRA are developed to reduce the number of latently infected cells; however, the impact of the period viral latency in hepatocytes especially, during HIV/HBV coinfection, needs to be investigated. Viral coinfection coupled with lifelong treatment of HIV/HBV necessitates investigation for the optimal control strategy. We propose a coinfection mathematical model with delay and use optimal control theory to analyse the effect of viral latency in hepatocytes on the dynamics of HIV/HBV coinfection. Analytical results indicate that HBV cannot take a competitive exclusion against HIV; thus, the coinfection endemic equilibrium implies chronic HBV in HIV-infected patients. Numerical and analytical results indicate that both HIV and HBV viral loads are higher with longer viral latency period in hepatocytes, which indicates the need to upgrade LRA to other non-CD4+ cell viral reservoirs. Higher viral load caused by viral latency coupled with the effects of cART partly explains why liver-related complications are the leading cause of mortality in HIV-infected persons.
format article
author Hasifa Nampala
Matylda Jablonska-Sabuka
Martin Singull
author_facet Hasifa Nampala
Matylda Jablonska-Sabuka
Martin Singull
author_sort Hasifa Nampala
title Mathematical Analysis of the Role of HIV/HBV Latency in Hepatocytes
title_short Mathematical Analysis of the Role of HIV/HBV Latency in Hepatocytes
title_full Mathematical Analysis of the Role of HIV/HBV Latency in Hepatocytes
title_fullStr Mathematical Analysis of the Role of HIV/HBV Latency in Hepatocytes
title_full_unstemmed Mathematical Analysis of the Role of HIV/HBV Latency in Hepatocytes
title_sort mathematical analysis of the role of hiv/hbv latency in hepatocytes
publisher Hindawi Limited
publishDate 2021
url https://doaj.org/article/a0b00266979c4b64b0e039ba9997e2de
work_keys_str_mv AT hasifanampala mathematicalanalysisoftheroleofhivhbvlatencyinhepatocytes
AT matyldajablonskasabuka mathematicalanalysisoftheroleofhivhbvlatencyinhepatocytes
AT martinsingull mathematicalanalysisoftheroleofhivhbvlatencyinhepatocytes
_version_ 1718407663831744512